Clinical Trial Update: MAX - SHOCK Clinical Trial [NA]

View source ↗

Summary

Clinical trial update for MAX - SHOCK (NCT06556667) sponsored by Ottawa Heart Institute Research Corporation; the study is currently recruiting for atrial fibri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: Ottawa Heart Institute Research Corporation | Conditions: Cardioversion, Atrial Fibrillation | NA | Status: RECRUITING